openPR Logo

Press Releases from biocrea GmbH (3 total)

biocrea and Boehringer Ingelheim Conclude Asset Purchase Agreement

Radebeul, Germany, February 29, 2012 – biocrea today announced the completion of an asset purchase and licensing deal with Boehringer Ingelheim. Under the terms of

biocrea’s first-in-class PDE2 inhibitor demonstrates strong potential for the …

- Data on novel PDE2 inhibitor BCA909 presented at 24th ECNP Congress in Paris - Radebeul, Germany, September 7, 2011 – biocrea, a biopharmaceutical company focusing

biocrea acquires CNS pipeline and PDE inhibitor platform from Biotie Therapies C …

- New entity will be based in Radebeul, Germany - Radebeul, Germany, November 4, 2010 – biocrea GmbH today announced further details about the newly incorporated

Go To Page: